Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 332 followers

Latest posts

Last updated about 13 hours ago

Human medicines European public assessment report (EPAR): Zavesca, miglustat, Date of authorisation: 20/11/2002, Date of refusal: 16/06/2009, Revision: 36, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Zavesca, miglustat, Date of authorisation...

Human medicines European public assessment report (EPAR): Ryzneuta, efbemalenograstim alfa, Date of authorisation: 21/03/2024, Revision: 5, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Ryzneuta, efbemalenograstim alfa, Date of...

Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Date of authorisation: 08/01/2018, Revision: 16, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Date...

CTIS Simplification Task Force: topics analysed

about 14 hours ago

CTIS Simplification Task Force: topics analysed

Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 9, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Mircera, methoxy polyethylene glycol-epoetin beta, Date of authorisation: 20/07/2007, Revision: 32, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Mircera, methoxy polyethylene glycol-epoetin beta...

Agenda - Sixteenth industry stakeholder platform on research and development support

about 15 hours ago

Agenda - Sixteenth industry stakeholder platform on research and development support

Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 12, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation...

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised

about 18 hours ago

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation...